 Connection
Larry Allen to Cardiovascular Diseases
This is a "connection" page, showing publications Larry Allen has written about Cardiovascular Diseases.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.069 |
|
|
|
-
Warraich HJ, Hernandez AF, Allen LA. How Medicine Has Changed the End of Life for Patients With Cardiovascular Disease. J Am Coll Cardiol. 2017 Sep 05; 70(10):1276-1289.
Score: 0.265
-
Birtcher KK, Allen LA, Anderson JL, Bonaca MP, Gluckman TJ, Hussain A, Kosiborod M, Mehta LS, Virani SS. 2022 ACC Expert Consensus Decision Pathway for Integrating Atherosclerotic Cardiovascular Disease and Multimorbidity Treatment: A Framework for Pragmatic, Patient-Centered Care: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2023 01 24; 81(3):292-317.
Score: 0.095
-
Luong P, Glorioso TJ, Grunwald GK, Peterson P, Allen LA, Khanna A, Waughtal J, Sandy L, Ho PM, Bull S. Text Message Medication Adherence Reminders Automated and Delivered at Scale Across Two Institutions: Testing the Nudge System: Pilot Study. Circ Cardiovasc Qual Outcomes. 2021 05; 14(5):e007015.
Score: 0.086
-
Angraal S, Caraballo C, Kahn P, Bhatnagar A, Singh B, Wilson FP, Fiuzat M, O'Connor CM, Allen LA, Desai NR, Mamtani R, Ahmad T. Geographical affiliation with top 10 NIH-funded academic medical centers and differences between mortality from cardiovascular disease and cancer. Am Heart J. 2020 12; 230:54-58.
Score: 0.082
-
Dalgaard F, North R, Pieper K, Fonarow GC, Kowey PR, Gersh BJ, Mahaffey KW, Pokorney S, Steinberg BA, Naccarrelli G, Allen LA, Reiffel JA, Ezekowitz M, Singer DE, Chan PS, Peterson ED, Piccini JP. Risk of major cardiovascular and neurologic events with obstructive sleep apnea among patients with atrial fibrillation. Am Heart J. 2020 05; 223:65-71.
Score: 0.078
-
Loring Z, Shrader P, Allen LA, Blanco R, Chan PS, Ezekowitz MD, Fonarow GC, Freeman JV, Gersh BJ, Mahaffey KW, Naccarelli GV, Pieper K, Reiffel JA, Singer DE, Steinberg BA, Thomas LE, Peterson ED, Piccini JP. Guideline-directed therapies for comorbidities and clinical outcomes among individuals with atrial fibrillation. Am Heart J. 2020 01; 219:21-30.
Score: 0.077
-
Morris PB, Kovacs RJ, Allen LA, Binder LG, Birtcher KK, Covington AM, Gluckman TJ, Williams KA. 2019 Methodology for Heart House Roundtables: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2019 08 27; 74(8):1116-1137.
Score: 0.075
-
Knoepke CE, Allen LA, Kramer DB, Matlock DD. Medicare Mandates for Shared Decision Making in Cardiovascular Device Placement. Circ Cardiovasc Qual Outcomes. 2019 07; 12(7):e004899.
Score: 0.075
-
Inohara T, Kim S, Pieper K, Blanco RG, Allen LA, Fonarow GC, Gersh BJ, Ezekowitz MD, Kowey PR, Reiffel JA, Naccarelli GV, Chan PS, Mahaffey KW, Singer DE, Freeman JV, Steinberg BA, Peterson ED, Piccini JP. B-type natriuretic peptide, disease progression and clinical outcomes in atrial fibrillation. Heart. 2019 03; 105(5):370-377.
Score: 0.071
-
Afilalo J, Alexander KP, Mack MJ, Maurer MS, Green P, Allen LA, Popma JJ, Ferrucci L, Forman DE. Frailty assessment in the cardiovascular care of older adults. J Am Coll Cardiol. 2014 Mar 04; 63(8):747-62.
Score: 0.051
-
Hess PL, Kim S, Piccini JP, Allen LA, Ansell JE, Chang P, Freeman JV, Gersh BJ, Kowey PR, Mahaffey KW, Thomas L, Peterson ED, Fonarow GC. Use of evidence-based cardiac prevention therapy among outpatients with atrial fibrillation. Am J Med. 2013 Jul; 126(7):625-32.e1.
Score: 0.050
-
Adams GL, Mills JS, Melloni C, Allen LA, Jolicoeur EM, Wang T, Chan M, Majidi M, Lopes RD. Highlights from the 56th annual scientific sessions of the American College of Cardiology: March 25 to 27, 2007, Atlanta, Georgia. Am Heart J. 2007 Aug; 154(2):247-59.
Score: 0.033
-
Inohara T, Shrader P, Pieper K, Blanco RG, Allen LA, Fonarow GC, Gersh BJ, Go AS, Ezekowitz MD, Kowey PR, Reiffel JA, Naccarelli GV, Chan PS, Mahaffey KW, Singer DE, Freeman JV, Steinberg BA, Peterson ED, Piccini JP. Treatment of atrial fibrillation with concomitant coronary or peripheral artery disease: Results from the outcomes registry for better informed treatment of atrial fibrillation II. Am Heart J. 2019 07; 213:81-90.
Score: 0.019
-
Holmqvist F, Guan N, Zhu Z, Kowey PR, Allen LA, Fonarow GC, Hylek EM, Mahaffey KW, Freeman JV, Chang P, Holmes DN, Peterson ED, Piccini JP, Gersh BJ. Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation-Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). Am Heart J. 2015 May; 169(5):647-654.e2.
Score: 0.014
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|